tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

NAGE Stock Latest News

Promising Growth and Innovation Drive Buy Rating for Niagen Bioscience
RatingsPromising Growth and Innovation Drive Buy Rating for Niagen Bioscience
19d ago
NAGE
Niagen Bioscience price target raised to $12 from $11 at H.C. Wainwright
PremiumThe Fly
Niagen Bioscience price target raised to $12 from $11 at H.C. Wainwright
21d ago
NAGE
Niagen Bioscience’s Robust Growth and Strategic Initiatives Drive Buy Rating
PremiumRatings
Niagen Bioscience’s Robust Growth and Strategic Initiatives Drive Buy Rating
25d ago
NAGE
Niagen Bioscience Reports Strong Q2 Growth and Outlook
PremiumCompany Announcements
Niagen Bioscience Reports Strong Q2 Growth and Outlook
25d ago
NAGE
Niagen Bioscience Reports Strong Q2 Sales Growth
PremiumCompany Announcements
Niagen Bioscience Reports Strong Q2 Sales Growth
26d ago
8K
NAGE
Niagen Bioscience reports Q2 EPS 4c, consensus 1c
PremiumThe FlyNiagen Bioscience reports Q2 EPS 4c, consensus 1c
26d ago
NAGE
Niagen Bioscience: Promising Clinical Results and Strategic IP Acquisitions Drive Buy Rating
Premium
Ratings
Niagen Bioscience: Promising Clinical Results and Strategic IP Acquisitions Drive Buy Rating
26d ago
NAGE
Niagen Bioscience Subsidiary Signs Supply Agreement
Premium
Company Announcements
Niagen Bioscience Subsidiary Signs Supply Agreement
1M ago
8K
NAGE
Niagen Bioscience licenses potential Parkinson’s therapy
PremiumThe Fly
Niagen Bioscience licenses potential Parkinson’s therapy
2M ago
NAGE
Niagen Bioscience Approves Equity Plan Amendment
PremiumCompany Announcements
Niagen Bioscience Approves Equity Plan Amendment
2M ago
8K
NAGE
Niagen Bioscience price target raised to $16 from $13 at Canaccord
PremiumThe Fly
Niagen Bioscience price target raised to $16 from $13 at Canaccord
3M ago
NAGE
Niagen Bioscience presents results in journal Aging Cell
PremiumThe Fly
Niagen Bioscience presents results in journal Aging Cell
3M ago
NAGE
Niagen Bioscience price target raised to $23 from $10 at Roth Capital
PremiumThe FlyNiagen Bioscience price target raised to $23 from $10 at Roth Capital
3M ago
NAGE
Canaccord starts Niagen Bioscience at Buy on ‘unique opportunity’
Premium
The Fly
Canaccord starts Niagen Bioscience at Buy on ‘unique opportunity’
3M ago
NAGE
Niagen Bioscience initiated with a Buy at Canaccord
Premium
The Fly
Niagen Bioscience initiated with a Buy at Canaccord
3M ago
NAGE
Niagen Biosciences Reports Strong Q1 2025 Growth
PremiumCompany Announcements
Niagen Biosciences Reports Strong Q1 2025 Growth
4M ago
NAGE
Niagen Bioscience’s Clinical Expansion and Strong Financial Performance Drive Buy Rating
PremiumRatings
Niagen Bioscience’s Clinical Expansion and Strong Financial Performance Drive Buy Rating
4M ago
NAGE
Niagen Bioscience Reports Strong Q1 2025 Growth
PremiumCompany Announcements
Niagen Bioscience Reports Strong Q1 2025 Growth
4M ago
NAGE
Closing Bell Movers: Arm sinks over 10% as guidance falls short
PremiumThe Fly
Closing Bell Movers: Arm sinks over 10% as guidance falls short
4M ago
G
Z
Niagen Bioscience Reports Strong Q1 2025 Financial Results
PremiumCompany AnnouncementsNiagen Bioscience Reports Strong Q1 2025 Financial Results
4M ago
8K
NAGE
Niagen Bioscience reports Q1 EPS 7c, consensus 2c
Premium
The Fly
Niagen Bioscience reports Q1 EPS 7c, consensus 2c
4M ago
NAGE
Niagen Bioscience sees FY25 revenue up 20%-25%, consensus $118.5M
Premium
The Fly
Niagen Bioscience sees FY25 revenue up 20%-25%, consensus $118.5M
4M ago
NAGE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >